Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2000 1
2001 3
2002 8
2003 5
2004 6
2005 9
2006 3
2007 2
2008 6
2009 9
2010 10
2011 9
2012 2
2013 5
2014 8
2015 12
2016 19
2017 20
2018 17
2019 8
2020 12
2021 11
2022 14
2023 12
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28592170

196 results

Results by year

Filters applied: . Clear all
Page 1
Current options to manage Waldenström's macroglobulinemia.
Benevolo G, Nicolosi M, Santambrogio E, Vitolo U. Benevolo G, et al. Expert Rev Hematol. 2017 Jul;10(7):637-647. doi: 10.1080/17474086.2017.1339596. Epub 2017 Jun 19. Expert Rev Hematol. 2017. PMID: 28592170 Review.
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP. Dimopoulos MA, et al. Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15. Blood. 2014. PMID: 25027391 Free PMC article. Review.
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.
Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Kapoor P, et al. JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. JAMA Oncol. 2017. PMID: 28056114 Free PMC article. Review.
Emerging drugs for Waldenström's macroglobulinemia.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Expert Opin Emerg Drugs. 2011 Mar;16(1):45-57. doi: 10.1517/14728214.2011.523418. Expert Opin Emerg Drugs. 2011. PMID: 21352069 Review.
[Waldenström's macroglobulinemia].
Poulain S, Wemeau M, Balkaran S, Hivert B, Hautecoeur A, Rossignol J, Fernandez J, Daudignon A, Roumier C, Soenen V, Lepelley P, Lai JL, Morel P, Leleu X. Poulain S, et al. Rev Med Interne. 2010 May;31(5):385-94. doi: 10.1016/j.revmed.2009.07.016. Epub 2010 Apr 3. Rev Med Interne. 2010. PMID: 20363537 French.
196 results